Concerns around COVID-19 are common in the general population, but cancer patients are also balancing questions about what the pandemic means for their treatment, prognosis, and vulnerability to the virus. A team of breast cancer experts at Memorial Sloan Kettering (MSK) shared their insights in a Patient Information Session on breast cancer and general breast health where they provided answers to some of the most frequently asked questions from breast cancer patients.
Over 500 members of the MSK community joined the session to have their questions answered. Topics ranged from what makes someone immunocompromised, to what MSK is doing to reduce the risk of COVID-19 at all our clinical locations, and how MSK is working to resume postponed breast cancer treatments. The event was hosted by Larry Norton, MD, Medical Director for the Evelyn H. Lauder Breast Center at MSK and featured other MSK experts specializing in all areas of breast health.
MSK plans to continue these Patient Information Sessions on a regular basis to help address concerns from our larger community on a variety of cancer-related issues. The next session scheduled for May 19th will specifically cover cancer surgery at MSK and will be moderated by MSK Chair of the Department of Surgery Jeffrey Drebin, MD, PhD.
The inaugural session, moderated by MSK Physician-in-Chief Lisa DeAngelis, MD, featured seven other MSK specialists, including those with expertise in Infectious Disease, Critical Care, Nursing, and Surgery.